The short version
21 companies supply this market — deep enough that no single failure threatens the supply.
Market view
38 marketed package NDCs · 21 active manufacturers
Most dispensed: 7 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 28 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 21 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 14 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle
21 companies supply this market — deep enough that no single failure threatens the supply.
Every detected change for memantine hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.